FDA Clearance Tracker · K243689
AVIEW
Last checked: Nov 19, 2026Latest source record: Mar 19, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 19, 2025
Substantially Equivalent
Time to decision
110 days
Received Nov 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243689
- Device name
- AVIEW
- Applicant
- Coreline Soft Co., Ltd.
- Applicant location
- Seoul, KR
- Received
- Nov 29, 2024
- Decided
- Mar 19, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.2050
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QIH. The earliest in FDA's data is K191171, decided Nov 13, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243689
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Coreline Soft Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AVIEW Aorta Metrics510(k)
K260391 · Decided Oct 16, 2026 · 252 days after receipt
Device type: System, X-Ray, Tomography, Computed (JAK) · Radiology & Imaging
- AVIEW Lung Nodule CAD510(k)
K251203 · Decided Dec 3, 2025 · 229 days after receipt
Device type: Lung Computed Tomography System, Computer-Aided Detection (OEB) · Radiology & Imaging
- AVIEW CAC510(k)
K243696 · Decided Feb 14, 2025 · 77 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.